SGLT1-sparing oral SGLT2 inhibitor prodrug launched in India for diabetes, 100 mg BID from mouse urine drug metabolite and opt. Bioorg. Med. Chem., Jan. 22, 2021 Kissei Pharma / Toho University, JP